Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Molecular characterization of Hepatitis C virus 3a in Peshawar

Authors: Amina Gul, Nabeela Zahid, Jawad Ahmed, Fazli Zahir, Imtiaz Ali Khan, Ijaz Ali

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The purpose of this study was to explore molecular epidemiology of HCV genotype 3a in Peshawar based on sequencing and phylogenetic analysis of Core region of HCV genome.

Methods

Chronically infected Hepatitis C virus infected patients enrolled under the Prime Minister Hepatitis C control program at three Tertiary care units of Peshawar [Khyber Teaching Hospital Peshawar, Lady Reading Hospital Peshawar, Hayat Abad Medical Complex Peshawar] were included in this cross sectional observational study. Qualitative detection of HCV and HCV genotyping was carried out by a modified reverse transcription-polymerase chain reaction (RT-PCR) and type specific genotyping assay. The Core gene of HCV genotype 3a was amplified, cloned and sequenced. The sequences obtained were used for phylogenetic analysis using MEGA 6 software.

Results

Among the 422 (82.75 %) PCR positive samples, 192 (45.5 %) were identified as having HCV genotype 3a infection. HCV Core gene sequencing was carried out randomly for the characterization of HCV 3a. Nucleotide sequence analysis of the obtained viral genomic sequences based on partial HCV 3a Core gene sequences with reference sequences from different countries showed that our sequences clustered with some local and regional sequences with high bootstrap values.

Conclusion

HCV 3a is highly prevalent in Peshawar, Pakistan and its phylogenetics based on Core gene sequences indicate the prevalence of different lineages of HCV 3a in Peshawar which may have consequences for disease management strategies causing more economic pressure on the impoverished population due to possible antiviral resistance.
Literature
1.
go back to reference Petta S, Craxi A. Current and future HCV therapy: do we still need other anti-HCV drugs? Liver Int. 2015;35(1):4–10.CrossRefPubMed Petta S, Craxi A. Current and future HCV therapy: do we still need other anti-HCV drugs? Liver Int. 2015;35(1):4–10.CrossRefPubMed
3.
go back to reference Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.CrossRefPubMed Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.CrossRefPubMed
4.
go back to reference Hill A, Khoo S, Fortunak J, Simmons B, Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin Infect Dis. 2014;58(7):928–36.CrossRefPubMedPubMedCentral Hill A, Khoo S, Fortunak J, Simmons B, Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin Infect Dis. 2014;58(7):928–36.CrossRefPubMedPubMedCentral
5.
go back to reference Ali A, Nisar M, Ahmad H, Saif N, Idrees M, Bajwa MA. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virol J. 2011;8:466.CrossRefPubMedPubMedCentral Ali A, Nisar M, Ahmad H, Saif N, Idrees M, Bajwa MA. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virol J. 2011;8:466.CrossRefPubMedPubMedCentral
6.
go back to reference Athar MA, Xu Y, Xie X, Xu Z, Ahmad V, Hayder Z, et al. Rapid detection of HCV genotyping 1a, 1b, 2a, 3a, 3b and 6a in a single reaction using two-melting temperature codes by a real-time PCR-based assay. J Virol Methods. 2015;222:85–90.CrossRefPubMed Athar MA, Xu Y, Xie X, Xu Z, Ahmad V, Hayder Z, et al. Rapid detection of HCV genotyping 1a, 1b, 2a, 3a, 3b and 6a in a single reaction using two-melting temperature codes by a real-time PCR-based assay. J Virol Methods. 2015;222:85–90.CrossRefPubMed
7.
go back to reference Nouroz FS, S Mujtaba G, Noreen S. An overview on hepatitis C virus genotypes, Egypt. J Med Hum Genet. 2015;16(4):291–8.CrossRef Nouroz FS, S Mujtaba G, Noreen S. An overview on hepatitis C virus genotypes, Egypt. J Med Hum Genet. 2015;16(4):291–8.CrossRef
8.
go back to reference Umar M, Bilal M, Hepatitis C. A Mega Menace: A Pakistani Perspective. J Pioneer Med Sci. 2012;2(2):68–72. Umar M, Bilal M, Hepatitis C. A Mega Menace: A Pakistani Perspective. J Pioneer Med Sci. 2012;2(2):68–72.
9.
go back to reference Salam A, Khan B, Sarwar N, Masoom G. Seroprevalnce of HBsAg and anti HCV in general population of Pakistan during 2012 and 2013. Prof Med J. 2014;21(4):766. Salam A, Khan B, Sarwar N, Masoom G. Seroprevalnce of HBsAg and anti HCV in general population of Pakistan during 2012 and 2013. Prof Med J. 2014;21(4):766.
10.
go back to reference Quer J, Gregori J, Rodriguez-Frias F, Buti M, Madejon A, Perez-del-Pulgar S, et al. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol. 2015;53(1):219–26.CrossRefPubMedPubMedCentral Quer J, Gregori J, Rodriguez-Frias F, Buti M, Madejon A, Perez-del-Pulgar S, et al. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol. 2015;53(1):219–26.CrossRefPubMedPubMedCentral
11.
go back to reference Tuplin A, Struthers M, Cook J, Bentley K, Evans DJ. Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3′ X-tail. Nucleic Acids Res. 2015;43(5):2914–26.CrossRefPubMedPubMedCentral Tuplin A, Struthers M, Cook J, Bentley K, Evans DJ. Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3′ X-tail. Nucleic Acids Res. 2015;43(5):2914–26.CrossRefPubMedPubMedCentral
13.
go back to reference Rasheed A, Ullah S, Naeem S, Zubair M, Ahmad W, Hussain Z. Occurrence of HCV genotypes in different age groups of patients from Lahore, Pakistan. Adv Life Sci. 2014;1(2):89–95. Rasheed A, Ullah S, Naeem S, Zubair M, Ahmad W, Hussain Z. Occurrence of HCV genotypes in different age groups of patients from Lahore, Pakistan. Adv Life Sci. 2014;1(2):89–95.
14.
go back to reference Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87.CrossRefPubMedPubMedCentral Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87.CrossRefPubMedPubMedCentral
15.
go back to reference Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol. 1996;77(12):3013–24.CrossRefPubMed Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol. 1996;77(12):3013–24.CrossRefPubMed
16.
18.
go back to reference Saludes V, Gonzalez V, Planas R, Matas L, Ausina V, Martro E. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol. 2014;20(13):3431–42.CrossRefPubMedPubMedCentral Saludes V, Gonzalez V, Planas R, Matas L, Ausina V, Martro E. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol. 2014;20(13):3431–42.CrossRefPubMedPubMedCentral
19.
go back to reference Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962–73.CrossRefPubMed Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962–73.CrossRefPubMed
20.
go back to reference Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74(11):2391–9.CrossRefPubMed Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74(11):2391–9.CrossRefPubMed
21.
go back to reference Waqas M, Parveen F, Waqar M, Ali A, Khan MA, Wasim M, et al. Distribution Pattern of Various Genotypes of HCV Circulating in District Mardan, Khyber Pakhtunkhwa, Pakistan. Advan Biol Res. 2015;9(2):69–74. Waqas M, Parveen F, Waqar M, Ali A, Khan MA, Wasim M, et al. Distribution Pattern of Various Genotypes of HCV Circulating in District Mardan, Khyber Pakhtunkhwa, Pakistan. Advan Biol Res. 2015;9(2):69–74.
22.
go back to reference Khan S, Attaullah S, Ayaz S, Niaz Khan S, Shams S, Ali I, et al. Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa. Virol J. 2011;8:105.CrossRefPubMedPubMedCentral Khan S, Attaullah S, Ayaz S, Niaz Khan S, Shams S, Ali I, et al. Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa. Virol J. 2011;8:105.CrossRefPubMedPubMedCentral
23.
go back to reference Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35(1):201–7.PubMedPubMedCentral Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35(1):201–7.PubMedPubMedCentral
24.
go back to reference Kanwal S, Mahmood T. Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan. Hepat Mon. 2012;12(6):398–407.CrossRefPubMedPubMedCentral Kanwal S, Mahmood T. Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan. Hepat Mon. 2012;12(6):398–407.CrossRefPubMedPubMedCentral
25.
go back to reference Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9.CrossRefPubMedPubMedCentral Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9.CrossRefPubMedPubMedCentral
26.
go back to reference Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318–27.CrossRefPubMedPubMedCentral Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318–27.CrossRefPubMedPubMedCentral
27.
go back to reference Sharafi H, Alavian S, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1), e24955.CrossRefPubMedPubMedCentral Sharafi H, Alavian S, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1), e24955.CrossRefPubMedPubMedCentral
28.
go back to reference Humphreys IS, Von Delft A, Brown A, Hibbert L, Collier JD, Foster GR, et al. HCV genotype-3a T cell immunity: specificity, function and impact of therapy. Gut. 2012;61(11):1589–99.CrossRefPubMedPubMedCentral Humphreys IS, Von Delft A, Brown A, Hibbert L, Collier JD, Foster GR, et al. HCV genotype-3a T cell immunity: specificity, function and impact of therapy. Gut. 2012;61(11):1589–99.CrossRefPubMedPubMedCentral
29.
go back to reference Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One. 2015;10(5), e0126764.CrossRefPubMedPubMedCentral Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One. 2015;10(5), e0126764.CrossRefPubMedPubMedCentral
31.
go back to reference Abro AH, Al-Dabal L, Younis NJ. Distribution of hepatitis C virus genotypes in Dubai, United Arab Emirates. J Pak Med Assoc. 2010;60(12):987–90.PubMed Abro AH, Al-Dabal L, Younis NJ. Distribution of hepatitis C virus genotypes in Dubai, United Arab Emirates. J Pak Med Assoc. 2010;60(12):987–90.PubMed
32.
33.
go back to reference Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, et al. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol. 2009;81(7):1189–97.CrossRefPubMed Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, et al. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol. 2009;81(7):1189–97.CrossRefPubMed
34.
go back to reference Afridi SQ, Ali MM, Awan F, Zahid MN, Afridi IQ, Afridi SQ, et al. Molecular epidemiology and viral load of HCV in different regions of Punjab, Pakistan. Virol J. 2014;11:24.CrossRefPubMedPubMedCentral Afridi SQ, Ali MM, Awan F, Zahid MN, Afridi IQ, Afridi SQ, et al. Molecular epidemiology and viral load of HCV in different regions of Punjab, Pakistan. Virol J. 2014;11:24.CrossRefPubMedPubMedCentral
35.
37.
go back to reference Khan TM, Mehr MT, Ullah H, Khan H, Iman NU. Frequency of hepatitis C genotypes in the North of Pakistan. Gomal J Med Sci. 2014;12(2):106–9. Khan TM, Mehr MT, Ullah H, Khan H, Iman NU. Frequency of hepatitis C genotypes in the North of Pakistan. Gomal J Med Sci. 2014;12(2):106–9.
38.
go back to reference Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G. Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon. 2012;12(3):196–204.CrossRefPubMedPubMedCentral Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G. Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon. 2012;12(3):196–204.CrossRefPubMedPubMedCentral
39.
go back to reference Chakravarti A, Ashraf A, Malik S. A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol. 2013;31(4):354–9.CrossRefPubMed Chakravarti A, Ashraf A, Malik S. A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol. 2013;31(4):354–9.CrossRefPubMed
40.
go back to reference Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1), e7991.CrossRefPubMedPubMedCentral Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1), e7991.CrossRefPubMedPubMedCentral
Metadata
Title
Molecular characterization of Hepatitis C virus 3a in Peshawar
Authors
Amina Gul
Nabeela Zahid
Jawad Ahmed
Fazli Zahir
Imtiaz Ali Khan
Ijaz Ali
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1488-0

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.